BishtRef
Articles Journals Publishers Authors Subjects Most Cited New Papers Year Stats Open Access
journal article Mar 02, 2021

The impact of COVID‐19 on head and neck cancer diagnosis and disease extent

Kimberley L. Kiong ORCID Edward M. Diaz Neil D. Gross ORCID Eduardo M. Diaz Ehab Y. Hanna
Head & Neck Vol. 43 No. 6 pp. 1890-1897 · Wiley
View at Publisher Save 10.1002/hed.26665
Abstract
AbstractBackgroundDue to COVID‐19, diagnostic delays and a surge of advanced head and neck cancer (HNC) is anticipated. We hereby evaluate patient and tumor characteristics before and during the early COVID‐19 period.MethodsRetrospective review of patients with HNC presented at a multidisciplinary tumor conference from May 14, 2020 to June 18, 2020 was performed and compared to a similar 6‐week period a year before. Demographics, time to diagnosis, and tumor characteristics were analyzed.ResultsThere was a 25% reduction in newly diagnosed malignancies. Groups were similar in baseline characteristics, duration of symptoms, and time to diagnosis. However, median primary tumor size was significantly larger (p = 0.042) and T stage more advanced for mucosal subsites (p = 0.025) in the COVID‐19 group.ConclusionOur findings suggest increased tumor burden in patients with HNC presenting during the pandemic, despite a similar time to diagnosis. This may become more pronounced as the pandemic duration is extended.
Topics

No keywords indexed for this article. Browse by subject →

References
35
[1]
CDC COVID. Data tracker.https://www.cdc.gov/covid-data-tracker/#cases. Accessed July 11 2020.
[2]
NCCN. Coronavirus disease 2019 (COVID‐19) resources for the cancer care community.https://www.nccn.org/covid-19/. Accessed July 11 2020.
[3]
ASCO. ASCO coronavirus resources.https://www.asco.org/asco-coronavirus-information. Accessed July 11 2020.
[4]
ESMO. ESMO COVID‐19 and cancer.https://www.esmo.org/covid-19-and-cancer. Accessed July 11 2020.
[18]
Han AY "Time for a paradigm shift in head and neck cancer management during the COVID‐19 pandemic" Otolaryngol Head Neck Surg (2020)
[21]
Cancer Research UK.https://www.cancerresearchuk.org/sites/default/files/april2020_cruk_hsc_submission_covid_cancer_final_public.pdf. Accessed July 11 2020.
[27]
US Census Bureau.https://www.census.gov/quickfacts/fact/table/US/PST045219. Accessed July 11 2020.
[28]
Racial Disparities in Patients With Head and Neck Squamous Cell Carcinoma

Christine G. Gourin, Robert H. Podolsky

The Laryngoscope 10.1097/01.mlg.0000224939.61503.83
[30]
National disparities in treatment package time for resected locally advanced head and neck cancer and impact on overall survival

David M. Guttmann, Julie Kobie, Surbhi Grover et al.

Head & Neck 10.1002/hed.25091
[34]
CDC: Cases and deaths in the US.https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/cases-in-us.html. Accessed July 11 2020.
Metrics
65
Citations
35
References
Details
Published
Mar 02, 2021
Vol/Issue
43(6)
Pages
1890-1897
License
View
Authors
K
Kimberley L. Kiong

Department of Head and Neck Surgery The University of Texas M. D. Anderson Cancer Center Houston Texas USA; Department of Otorhinolaryngology – Head and Neck Surgery Singapore General Hospital Singapore Singapore

E
Edward M. Diaz

Department of Head and Neck Surgery The University of Texas M. D. Anderson Cancer Center Houston Texas USA

N
Neil D. Gross

Department of Head and Neck Surgery The University of Texas M. D. Anderson Cancer Center Houston Texas USA

E
Eduardo M. Diaz

Department of Head and Neck Surgery The University of Texas M. D. Anderson Cancer Center Houston Texas USA

E
Ehab Y. Hanna

Department of Head and Neck Surgery The University of Texas M. D. Anderson Cancer Center Houston Texas USA

Cite This Article
Kimberley L. Kiong, Edward M. Diaz, Neil D. Gross, et al. (2021). The impact of COVID‐19 on head and neck cancer diagnosis and disease extent. Head & Neck, 43(6), 1890-1897. https://doi.org/10.1002/hed.26665
Related

You May Also Like

Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)

Jacques Bernier, Jay S. Cooper · 2005

1,521 citations

The addition of mood and anxiety domains to the University of Washington quality of life scale

Simon N. Rogers, Suzanne Gwanne · 2002

358 citations

Prognostic factors of clinically stage I and II oral tongue carcinoma—A comparative study of stage, thickness, shape, growth pattern, invasive front malignancy grading, martinez‐gimeno score, and pathologic features

Anthony Po Wing Yuen, King Yin Lam · 2002

287 citations

p16 expression as a surrogate marker for HPV‐related oropharyngeal carcinoma: A guide for interpretative relevance and consistency

Adel K. El‐Naggar, William H. Westra · 2011

262 citations

Vascularized bone flaps versus nonvascularized bone grafts for mandibular reconstruction: An outcome analysis of primary bony union and endosseous implant success

Robert D. Foster, James P. Anthony · 1999

260 citations